Brands and Their Owners
Welcome to the Brand page for “K”, which is offered here for The mark consists of several geometric designs that form the basic elements of an animal face and the letter k forming the base of the face.;pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases;color is not claimed as a feature of the mark.;research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; development of pharmaceutical preparations and medicines; drug development and discovery; medical research for development of therapeutic modalities for treatment of diseases; assays and reagents for use in scientific and biomedical research; clinical studies; preclinical and clinical development of therapeutic products;.
Its status is currently believed to be active. Its class is unavailable. “K” is believed to be currently owned by “Kymera Therapeutics, Inc.”
Owner: |
KYMERA THERAPEUTICS, INC.
Owner Details |
---|---|
Description: |
The mark consists of several geometric designs that form the basic elements of an animal face and the letter K forming the base of the face.;pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases;Color is not claimed as a feature of the mark.;Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Assays and reagents for use in scientific and biomedical research; Clinical studies; Preclinical and clinical development of therapeutic products;
|
Categories: |